Kim Do-Yoon, Won Kyung-Jong, Yoon Mi-So, Yu Ho-Jin, Park Joo-Hoon, Kim Bokyung, Lee Hwan Myung
Department of Cosmetic Science, College of Natural Science, Hoseo University , Asan, Chungnam Prefecture , Republic of Korea and.
Pharm Biol. 2015 May;53(5):725-34. doi: 10.3109/13880209.2014.941882. Epub 2014 Oct 21.
Chrysanthemum boreale Makino (Compositae) (CBM) is a traditional medicine that has been used for the prevention or treatment of various disorders; it has various properties including antioxidation, anti-inflammation, and antitumor.
The present study was designed to explore the in vitro effect of CBM flower floral water (CBMFF) on atherosclerosis-related responses in rat aortic smooth muscle cells (RASMCs).
CBMFF was extracted from CBM flower by steam distillation and analyzed using gas chromatography-mass spectrometry. The anti-atherosclerosis activity of CBMFF was tested by estimating platelet-derived growth factor (PDGF)-BB (10 ng/mL)-induced proliferation and migration levels and intracellular kinase pathways in RASMCs at CBMFF concentrations of 0.01-100 μM and analyzing ex vivo aortic ring assay.
Gas chromatography-mass spectrometry showed that the CBMFF contained a total of seven components. The CBMFF inhibits PDGF-BB-stimulated RASMC migration and proliferation (IC50: 0.010 μg/mL). Treatment of RASMCs with PDGF-BB induced PDGFR-β phosphorylation and increased the phosphorylations of MAPK p38 and ERK1/2. CBMFF addition prevented PDGF-BB-induced phosphorylation of these kinases (IC50: 008 and 0.018 μg/mL, for p38 MAPK and ERK1/2, respectively), as well as PDGFR-β (IC50: 0.046 μg/mL). Treatment with inhibitors of PDGFR, P38 MAPK, and ERK1/2 decreased PDGF-BB-increased migration and proliferation in RASMCs. Moreover, the CBMFF suppressed PDGF-BB-increased sprout outgrowth of aortic rings (IC50: 0.047 μg/mL).
These results demonstrate that CBMFF may inhibit PDGF-BB-induced vascular migration and proliferation, most likely through inhibition of the PDGFR-β-mediated MAPK pathway; therefore, the CBMFF may be promising candidate for the development of herbal remedies for vascular disorders.
野菊花(菊科)是一种传统药物,已被用于预防或治疗各种疾病;它具有多种特性,包括抗氧化、抗炎和抗肿瘤。
本研究旨在探讨野菊花花水(CBMFF)对大鼠主动脉平滑肌细胞(RASMCs)中动脉粥样硬化相关反应的体外作用。
通过水蒸气蒸馏从野菊花中提取CBMFF,并采用气相色谱 - 质谱联用仪进行分析。在CBMFF浓度为0.01 - 100 μM的条件下,通过评估血小板衍生生长因子(PDGF)-BB(10 ng/mL)诱导的RASMCs增殖和迁移水平以及细胞内激酶途径,并分析离体主动脉环试验,来测试CBMFF的抗动脉粥样硬化活性。
气相色谱 - 质谱联用分析表明,CBMFF共含有七种成分。CBMFF可抑制PDGF - BB刺激的RASMC迁移和增殖(IC50:0.010 μg/mL)。用PDGF - BB处理RASMCs可诱导PDGFR - β磷酸化,并增加MAPK p38和ERK1/2的磷酸化水平。添加CBMFF可阻止PDGF - BB诱导的这些激酶的磷酸化(p38 MAPK和ERK1/2的IC50分别为0.008和0.018 μg/mL),以及PDGFR - β的磷酸化(IC50:0.046 μg/mL)。用PDGFR、P38 MAPK和ERK1/2的抑制剂处理可降低PDGF - BB诱导的RASMCs迁移和增殖。此外,CBMFF可抑制PDGF - BB诱导的主动脉环芽生生长(IC50:0.047 μg/mL)。
这些结果表明,CBMFF可能通过抑制PDGFR - β介导的MAPK途径来抑制PDGF - BB诱导的血管迁移和增殖;因此,CBMFF可能是开发血管疾病草药疗法的有前途的候选药物。